Alfalfa Leaves Replace Insulin as A Hypoglycemic, Antidiabetic and Insulinotropic

Abstract

In this study, the effect of alfalfa leaves with the scientific name Medicago sativa L. from the Bean family on reducing blood sugar was investigated. The key is to find a suitable alternative to insulin with easy-to-use, noside, low-cost features. The main result of the research is to find a suitable sample and introduce it. Numerous plants have previously been introduced with relatively similar medicinal effects, even for regulating blood sugar, but this is the first time in the world that alfalfa leaves have been used safely in clinical trials without the usual research complexities; it is proposed as an alternative to insulin by presenting laboratory and human clinical results. The result of the plan; It has a medicinal application and is required by the medical sector of the country. Sample in the form of oral capsules in three comparative daily meals (blood sugar level before consumption and one hour after consumption of oral capsules) on eleven type 1 diabetic patients and volunteers with glucometer and one healthy volunteer in a specialized laboratory Pathobiology was studied and after laboratory and clinical examinations on eleven volunteer patients and a healthy person and registered results, it can be concluded that this plant has shown optimal activity in terms of reducing blood sugar. According to the experiments, the median of non-fasting blood sugar was 52.57 for the morning meal, 53.54 for the noon meal and 53.82 for the evening meal per mg/dl for 11 volunteer patients as randomized. And the exact amount of hypoglycemia in the morning for a healthy person 55 mg/dl obtained and the role of effective compounds in alfalfa leaves in a significant reduction and significantly confirmed blood sugar.